Kenny, H. L., Mastrolonardo, E., Linnenbach, A., Tuluc, M., Gargano, S., Keith, S. W., Bar-Ad, V., Shi, W., Thal, A., Goldman, R. A., Cognetti, D., Luginbuhl, A. J., Choe, J. H., Topf, M., Aya, L. H., Weed, D., Lally, S. E., Shields, C., Johnson, J. M., Curry, J. M. (2026). A phase II study of neoadjuvant cemiplimab in hedgehog inhibitor (HHI)–naive basal cell carcinoma of the head and neck.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2026.44.16_suppl.9515